Age specific differences in pediatric obstructive sleep apnea

Debra M Don1, Kenneth A Geller, Jeffrey A Koempel

  • 1Division of Pediatric Otolaryngology and Pulmonology, Childrens Hospital Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA. ddon@chla.usc.edu

Insights

Younger children, particularly those under 3, show a higher incidence of severe obstructive sleep apnea (OSA). This age group also experiences more central apneas, suggesting a need for careful monitoring post-surgery.

Area of Science:

  • Pediatric Sleep Medicine
  • Respiratory Physiology
  • Otolaryngology

Background:

  • Obstructive sleep apnea (OSA) severity may differ between younger and older children.
  • Younger children might face higher respiratory risks post-tonsillectomy and adenoidectomy.
  • Limited studies have explored the age-related correlation with OSA severity.

Purpose of the Study:

  • To investigate age-specific variations in obstructive sleep apnea severity among pediatric patients.
  • To determine if younger children exhibit distinct OSA patterns compared to older children.

Main Methods:

  • Retrospective chart review of children aged 1-18 diagnosed with OSA via polysomnography.
  • Analysis included apnea-hypopnea index (AHI), oxygen saturation, end-tidal CO2, and apnea types.
  • Children were grouped by age: 1-2, 3-5, 6-11, and 12-18 years.

Main Results:

  • While a trend suggested more severe OSA in younger children, statistical significance was limited for most parameters.
  • Analysis of variance revealed significant differences (p<0.01) in AHI and apnea types between the 1-2 year olds and older groups.
  • Children aged 1-2 years showed a higher proportion in moderate to severe OSA categories (p<0.01).

Conclusions:

  • Children under 3 years old demonstrate a predisposition for more severe obstructive sleep apnea.
  • Central apneas are also more prevalent in this younger demographic.
  • Age-related anatomical and physiological differences may explain these findings, supporting post-adenotonsillectomy observation in young children.
Abstract

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...